In this webinar you learn of a new unique method to select the ELISA with the broadest coverage of HCPs in your purification process.
You get examples of how the ground-breaking Alphalyse Coverage Method provides you with detailed coverage information about individual HCPs – accurately – without 2D Western blotting!
Attend if you are a manager or scientist in R&D or process development and concerned about the Host Cell Proteins (HCPs) in your biologic.
Key Learning Objectives:
- Acquire the newest knowledge on how to evaluate HCP ELISAs – without spot counting or other imprecise methods
- Learn how to select the most suitable ELISA for your biologic - with the highest HCP coverage
- Get examples of our 60+ HCP projects – and how our clients save up to 2 years and €500.000 on biologic development
Rikke Lund, PhD
HCP Team Leader
Rikke Lund has a background in medical protein research with a PhD in Cancer Proteomics from Institute of Molecular Medicine, University of Southern Denmark.
After working 10 years within medical proteomics, Rikke is now heading the HCP team at Alphalyse and has established advanced HCP analysis services provided to Biopharma companies. For the last two years, her team has been leading a project joining ELISA and Antibody experts, MS experts and Pharma companies to develop improved coverage methods for HCP-ELISA antibodies.
Cost: No Cost!